Violation Tracker Parent Company Summary
|Top 5 Offense Groups (Groups Defined)||Penalty Total||Number of Records|
|Top 5 Primary Offense Types||Penalty Total||Number of Records|
|drug or medical equipment safety violation||$502,300,000||3|
|False Claims Act and related||$43,625,000||3|
|price-fixing or anti-competitive practices||$150,000||1|
|workplace safety or health violation||$9,620||1|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
DUSA Pharmaceuticals, Inc.; Ranbaxy; Ranbaxy Laboratories; Ranbaxy Pharmaceuticals, Inc.; Ranbaxy Pharmaceuticals, Inc. et al.; RANBAXY USA; SUN PHARMACEUTICAL IND
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Ranbaxy USA Inc.||drug or medical equipment safety violation||2013||FDA||$500,000,000|
|Ranbaxy||drug or medical equipment safety violation||2013||MULTI-AG||(*) $266,729,715|
|DUSA Pharmaceuticals, Inc.||False Claims Act and related||2020||DOJ_CIVIL||$20,750,000|
|Ranbaxy Pharmaceuticals, Inc. et al.||False Claims Act and related||2014||TX-AG||$17,875,000|
|Ranbaxy||False Claims Act and related||2013||LA-AG||$5,000,000|
|Ranbaxy Laboratories||drug or medical equipment safety violation||2014||OR-AG||$2,300,000|
|Ranbaxy Pharmaceuticals, Inc.||price-fixing or anti-competitive practices||2014||NY-AG||$150,000|
|SUN PHARMACEUTICAL INDUSTRIES, INC.||workplace safety or health violation||2016||OSHA||$9,620|